Veracyte's Decipher Prostate Genomic Classifier can predict which men with very high-risk nonmetastatic prostate cancer will benefit from adding abiraterone to androgen deprivation therapy (ADT). This finding, from a Phase III STAMPEDE trial analysis, helps doctors identify patients likely to see improved outcomes and avoid unnecessary side effects. The data, presented at ESMO 2026, supports more personalized treatment decisions and may lead to broader use of Decipher in clinical practice. Further validation is underway in ongoing trials like NRG-GU009 (PREDICT-RT).
Veracyte’s Decipher Prostate Genomic Classifier is highlighted here with Pluang’s Health-sector market snapshot for context. As of Oct 23, 2026 14:31 WIB, among 150 priced Health-sector US stocks tradable on Pluang, 63 rose and 85 fell. Notable movers include NTRA at USD 398.34 with a 1-day change of -3.64% and a typical hold time of 8 days, TNGX at USD 27.91 with a 1-day change of +3.45% and 100% buy order activity, and BNGO at USD 1.22 with a 1-day change of +3.39% and a typical hold time of 51 days.
BDR Pharmaceuticals has filed a lawsuit against the FDA, disputing the agency's refusal to accept an abbreviated new drug application referencing Phathom Pharmaceuticals' VOQUEZNA. BDR claims the FDA wrongly extended Phathom's exclusivity period unde...
Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...
Ipsos posted €636.2 million revenue in Q3 2026 with 2.0% organic growth, up from 0.8% in H1, led by strong performances in EMEA, China, and its Citizens business. The company updated its full-year organic growth outlook to 1.2%-1.5%, citing ongoing g...
Signify reported third-quarter 2026 results with sales of EUR 1,367 million, a slight decline in comparable sales by 3.4%, but improved adjusted EBITA of EUR 145 million and a margin increase to 10.6%. Net income rose to EUR 88 million and free cash ...
Jupiter Mobile users can now use Revolut Pay to buy cryptocurrencies, integrating the popular payment service with the Solana-based trading platform. JupiterExchange operates exclusively on Solana, aggregating orders across multiple liquidity sources...
